To summarize cancer-related MGL binding, an interaction with MGL has been described for many types of cancers including colon cancer, breast cancer, cervical cancer, glioblastoma, ovarian cancer, or acute T-cell leukemia. This evidence concerns the gene CLEC10A and breast cancer.